ストックスクリーナーアプリを入手
1.88
6.00%
-0.12
アフターアワーズ：
1.88
前日終値:
$2.00
開ける：
$1.94
24時間の取引高:
483.50K
Relative Volume:
0.64
時価総額：
$127.40M
収益：
-
当期純損益:
$-64.20M
株価収益率:
-0.8744
EPS:
-2.15
ネットキャッシュフロー:
$57,000
1週間 パフォーマンス:
-9.62%
1か月 パフォーマンス:
-5.05%
6か月 パフォーマンス:
+48.03%
1年 パフォーマンス:
-46.44%
1日の値動き範囲:
$1.85
$1.97
1週間の範囲:
$1.85
$2.18
52週間の値動き範囲:
$1.05
$4.34
Climb Bio Inc Stock (CLYM) Company Profile
CLYM を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.88 | 135.53M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-16 | 開始されました | William Blair | Outperform |
| 2025-10-13 | 開始されました | H.C. Wainwright | Buy |
| 2025-08-15 | 開始されました | Robert W. Baird | Outperform |
| 2025-06-06 | 開始されました | Oppenheimer | Outperform |
| 2025-05-22 | 開始されました | BTIG Research | Buy |
| 2024-12-02 | 開始されました | Leerink Partners | Outperform |
すべてを表示
Climb Bio Inc (CLYM) 最新ニュース
Can momentum traders help lift Climb Bio Inc.July 2025 Fed Impact & Stock Portfolio Risk Management - newser.com
How sustainable is Climb Bio Inc. stock dividend payoutEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Will Climb Bio Inc. stock go up soonWeekly Loss Report & AI Based Buy/Sell Signal Reports - newser.com
Is Climb Bio Inc. stock entering bullish territoryEarnings Recap Summary & Real-Time Volume Analysis Alerts - newser.com
Why Climb Bio Inc. stock is recommended by analystsJuly 2025 Spike Watch & Low Risk Profit Maximizing Plans - newser.com
Can Climb Bio Inc. stock maintain operating margins2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Visualizing Climb Bio Inc. stock with heatmapsJuly 2025 Levels & Low Drawdown Momentum Ideas - newser.com
Momentum divergence signals in Climb Bio Inc. chartSell Signal & Verified Stock Trade Ideas - newser.com
Climb Bio to Present at Upcoming Investor Conferences - The Manila Times
Climb Bio (Nasdaq: CLYM) to join Guggenheim, Baird and Piper Sandler events; webcasts - Stock Titan
Using R and stats models for Climb Bio Inc. forecastingWeekly Stock Report & Community Consensus Stock Picks - newser.com
Predicting Climb Bio Inc. trend using moving averagesQuarterly Trade Summary & Advanced Swing Trade Entry Alerts - newser.com
Strategies to average down on Climb Bio Inc.Analyst Downgrade & Reliable Price Action Trade Plans - newser.com
Has Climb Bio Inc. formed a bullish divergenceMarket Rally & Risk Managed Investment Strategies - newser.com
What institutional flow reveals about Climb Bio Inc.Weekly Investment Summary & Community Consensus Stock Picks - newser.com
William Blair Initiates Coverage of Climb Bio (CLYM) with Outperform Rating on Autoimmune Drug Potential - Insider Monkey
10 Best Stocks Under $3 to Invest In - Insider Monkey
Climb Bio, Inc. (NASDAQ:CLYM) Given Average Recommendation of "Buy" by Brokerages - MarketBeat
Climb Bio Inc (CLYM) 財務データ
収益
当期純利益
現金流量
EPS
Climb Bio Inc (CLYM) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Pimblett Emily | SVP, Finance & CAO |
Jun 20 '25 |
Sale |
1.24 |
1,242 |
1,540 |
18,888 |
| Pimblett Emily | SVP, Finance & CAO |
Mar 20 '25 |
Sale |
1.31 |
1,199 |
1,571 |
15,130 |
| Pimblett Emily | CHIEF ACCOUNTING OFFICER |
Dec 19 '24 |
Sale |
2.02 |
1,235 |
2,495 |
11,329 |
1.45%
0.86%
大文字化:
|
ボリューム (24 時間):